Fairmount Healthcare Co-Invest V L.P. — SEC Form 4 filings

SEC reporting owner CIK 2091559. 2 Form 4 filings on record with FilingPulse; latest filed 2026-03-25.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2026-02-12 to 2026-03-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Damora Therapeutics, Inc. (DMRA)Director, 10% owner25

Form 4 filings — Fairmount Healthcare Co-Invest V L.P.

FiledFormIssuerReported transactionsSource
2026-03-254Damora Therapeutics, Inc. (DMRA)
jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Kiselak Tomas, Harwin Peter Evan
Grant/award (A): 37,313 (derivative) @ $0EDGAR
2026-02-124Galecto, Inc. (GLTO)
jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Kiselak Tomas, Harwin Peter Evan
Option exercise (M): 5,809,000 @ $0 · Option exercise (M): 2,904,000 @ $0 · Option exercise (M): 5,809 (derivative) @ $0 · Option exercise (M): 2,904 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2091559 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →